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Abstract Chronic daily headaches
(CDHs) refers to primary
headaches that happen on at least
15 days per month, for 4 or more
hours per day, for at least three
consecutive months. The differen-
tial diagnosis of CDHs is challeng-
ing and should proceed in an
orderly fashion. The approach
begins with a search for “red
flags” that suggest the possibility
of a secondary headache. If sec-
ondary headaches that mimic
CDHs are excluded, either on clin-
ical grounds or through investiga-
tion, the next step is to classify the
headaches based on the duration of
attacks. If the attacks last less than
4 hours per day, a trigeminal auto-
nomic cephalalgia (TAC) is likely T T .
TACs include episodic and chronic
cluster headache, episodic and
chronic paroxysmal hemicrania,
SUNCT, and hypnic headache. If
the duration is ≥4 h, a CDH is
likely and the differential diagno-
sis encompasses chronic migraine,
chronic tension-type headache,
new daily persistent headache and
hemicrania continua. The clinical
approach to diagnosing CDH is the
scope of this review.
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Introduction
Chronic daily headaches (CDH) may be broadly or nar-
rowly defined. In the broad sense, CDH encompasses all
headaches that occur on 15 days per month or more. They
are subdivided in primary CDHs (not caused by other dis-
orders) and secondary CDHs (there is an underlying cause
such as infection or tumour). The primary CDHs are fur-
ther subdivided into those of long duration (≥4 h a day)
and shorter duration (<4 h duration) [1–3].
In its narrow and more frequently used sense, CDH is
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tion”, a clinical syndrome defined by headaches that occur
for ≥4 h a day on ≥15 days a month over >3 months in
individuals without an underlying cause [1]. Unless other-
wise indicated, in this paper, CDH refers to primary CDHs
of long duration.
CDH is the third most common primary headache in
the population, with an overall prevalence ranging from
4% to 5% [4, 5]. Because of their frequency, severity and
duration, CDHs are extraordinarily burdensome to individ-
uals and society. Furthermore, CDH is the most common
reason for consultation in headache clinics.
The Silberstein and Lipton (S-L) criteria for CDH and its
subtypes have been widely used and are well accepted [1].
According to these criteria, CDH is divided into four groups:
chronic or transformed migraine (CM/TM), chronic tension-
type  headache (CTTH), new daily persistent  headache
(NDPH) and hemicrania continua (HC), and subclassified
into subtypes with medication overuse or without medication
overuse, incorporating the concept that medication overuse
is often associated with the onset of CDH.
The differential diagnosis of CDHs is challenging and f f
should proceed  in an orderly  fashion. Crucial e lements
include a thorough history, supplemented by general med-
ical and neurological examinations, as well as laboratory
testing and neuroimaging in selected patients. Herein we
discuss the strategy to diagnose CDHs and their differen- f f
tial diagnosis. We W W emphasise that this strategy reflects the
authors’ personal view of CDHs, as well as our personal
diagnostic experience. Furthermore, the diagnostic algo-
rithms presented herein have not been validated.
First step: distinguishing primary from secondary CDH
An important first step in headache diagnosis is to distin-
guish primary from secondary CDH. The detailed strate-
gies to identify or exclude secondary  headaches are
beyond t he scope of t his paper. In brief, the approach
begins with a search for “red flags” that suggest the possi-
bility of a secondary headache (Fig. 1). Once these fea-
tures are identified, the physician must conduct the appro-
priate work-up to identify or exclude the conditions sug-
gested by the red flag (Table 1). Once secondary headache
is excluded by history, physical and neurological examina-
tion and/or appropriate testing, the next step is to diagnose
the primary headache disorder [6].
Many patients with red flags do not have secondary
headache disorders. Nonetheless, when red flags are pre-
sent, they often merit investigation. Red flags include: (1)
sudden onset of a severe headache; (2) a worsening pattern
of a preexisting headache in the absence of obvious predis-
posing factors (e.g. medication overuse, depression); (3)
headache with cancer, HIV or other systemic illness (fever,
neck stiffness, cutaneous rash); (4) headache associated f f
Fig. 1 Algorithm for headache diagnosis. Modified from [25]
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with focal neurologic signs other than typical visual or
sensory aura; (5) headache in a patient with papilloedema;
(6) moderate or severe headache triggered by cough, exer-
tion, orgasm or Valsalva; and (7) new onset of a headache
during pregnancy or post-partum.
Other  less common secondary causes of  intractable
headache that may lead to CDH are summarised in Table
2. Detection of many of these disorders requires a system-
atic approach to the headache history and physical exami-
nation as well as a high index of suspicion. We will high-
light some of these critical issues. For a review on this
topic, the reader is referred to [7].
Red flags triggered by the temporal profile of headache
The temporal profile of the headache, and its nature and
the circumstances of its onset are crucial for diagnosis. The
temporal profile of a headache can provide important clues
to its aetiology. A few examples are listed below:
• A rapid-onset headache may suggest a subarachnoid haem-
orrhage, pituitary apoplexy [8] or other intracranial catastro-
phes [9]. These disorders rarely cause CDH, but can result in
intractability of an ongoing headache attack.
Table 1 Red flags in the diagnosis of headache. Modified from [6]
Red flag Consider Possible investigation(s)
Sudden-onset headacheS u barachnoid haemorrhage, bleed into a mass  Neuroimaging, lumbar puncture
or AVM, mass lesion (especially posterior fossa) (after neuroimaging evaluation)
Worsening-pattern headache Mass lesion, subdural haematoma, medication overuse Neuroimaging
Headache with cancer, HIV or other  Meningitis, encephalitis, Lyme disease, systemic Neuroimaging, lumbar puncture, biopsy,
systemic illness (fever, neck stiffness,  infection, collagen vascular disease, arteritis blood tests
cutaneous rash)
Focal neurologic signs, or symptoms  Mass lesion, AVM, collagen vascular disease Neuroimaging, collagen vascular
other than typical visual or sensory aura evaluation
Papilloedema Mass lesion, pseudotumour, encephalitis, meningitis Neuroimaging, lumbar puncture
(after neuroimaging evaluation)
Triggered by cough, exertion or Valsalva Subarachnoid haemorrhage, mass lesion Neuroimaging, consider lumbar
puncture
Headache during pregnancy or post-partum Cortical vein/cranial sinus thrombosis, carotid  Neuroimaging
dissection, pituitary apoplexy
Table 2 Secondary headaches that mimic chronic benign headache syndromes
Headache associated with vascular disorders
Cerebrovascular disease including carotid artery dissection and arteriovenous malformation
Arteritis including giant cell arteritis
Headache associated with non-vascular intracranial disorders
Low CSF pressure syndrome (spontaneous or post-traumatic CSF “leak”)
High CSF pressure without papilloedema
Intracranial: Lyme disease, human immunodeficiency virus, encephalitis, fungal meningitis, etc.
Headache associated with substances or their withdrawal
Overuse of acute headache medications (rebound or toxic drug overuse syndromes)
Headache associated with cranium, neck, eyes, ears, nose, sinuses, teeth, mouth or other facial or cranial structures
Otolaryngologic disease, including chronic sphenoid sinusitis (or other sinus disease)
Nasopharyngeal disorders, including carcinoma
Disorders of the trigeminal nerve, including dental and oral disease, jaw pathology
Subacute angle closure glaucoma, optic neuritis and other ocular disorders
Occipitocervical disease, including Arnold-Chiari Malformation Type I; upper cervical joint, root or nerve (neuralgic) syndromes
Headache associated with non-cephalic infection, metabolic or systemic disturbances
Hepatitis, renal disease, B12 deficiency, anaemia, exposure to carbon monoxide and other toxins
Hormonal disturbances/endocrinologic disease (oestrogen, thyroid disease, hyperprolactinaemia, etc.)
Vasculitis/rheumatic/connective tissue disorders V V
Miscellanea
Mediastinal and thoracic processes including angina, mass lesions, superior vena cava syndrome• Sphenoid sinusitis may cause NDPH and may be missed
radiologically unless appropriate studies are performed [10].
• Headaches that start after age 55 suggest an organic dis-
order for CDH, such as a mass lesion or giant cell arteritis
[11]. Giant cell arteritis is often under-diagnosed, and is an
important cause of preventable blindness in the elderly.
Red  flags triggered  by concurrent events or provoking
activity
Concurrent events and headache triggers may give clues to
diagnosis, and some of them are listed below:
• Chronic headaches (NDPH) that occur in the peripartum
period may be due to dural sinus thrombosis [12].
• Orthostatic CDH suggests a low CSF pressure headache
(from a spontaneous CSF leak, a previous lumbar punc-
ture, or an epidural block) [13].
• CDH exacerbated by straining, coughing or sneezing
suggests a hindbrain malformation, occipitocervical junc-
tion disorder or increased intracranial pressure [14].
• CDH that is worse in the morning in the absence of med-
ication overuse, that may suggest raised intracranial pres-
sure. CDH with medication overuse is often worse in the
morning.
• In contrast, subjects with CDH that is better in the morn-
ing and worse at night that may suggest low CSF volume
headache [13].
• Similarly, CDHs that are worse on awakening sometimes
occur with obstructive sleep apnoea [13].
• Increasing pain while upright, and neck pain and
headache provoked  by flexion or extension of the neck
might suggest an occipitocervical junction disorder or a
systemic medical illness [15–17].
• Search for opportunistic infections, including toxoplas-
mosis and cryptococcal meningitis, in patients who may
have HIV infection or HIV risk factors [18].
• A previous mild to moderate head or neck injury is fre-
quently overlooked in the standard history, despite the fact
that  it can render an individual refractory to standard
headache treatments [19]. A diagnosis of post-traumatic
headache may lead to additional treatment including trig-
ger point  injections and  facet  joint and cervical nerve
blocks.
• The history often neglects recent dental procedures. Root
canals, tooth extractions or bite disturbances may provoke
or be associated with the development of CDH due to brain
abscess [20, 21].
• Consider ocular disturbances, such as subacute angle clo-
sure glaucoma, or infection, if the CDH is worse in the
periorbital region [22].
• Nasal blockage, drainage, pus or pressure may suggest
sinus disease [23]. Nasopharyngeal carcinoma can produce
chronic head and face pain and can be identified by
detailed, expert examination of the nasopharynx or neu-
roimaging [24].
In the absence of secondary CDH, the clinician proceeds
to diagnose a primary CDH disorder. If the headache is atyp-
ical or difficult to classify f f , the possibility o f secondary
headache should be reconsidered, although the modifying
effect of any treatment being taken should be kept in mind. f f
Additionally, lack of response to appropriate treatment given
for enough time may also be considered a red flag.
Second step: classifying primary CDH based on duration
and frequency (Fig. 2)
Basically, in a patient where we excluded, either by clini-
Fig. 2 Algorithm for classifying primary headaches based on frequency and duration
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cal history or by appropriate investigation, secondary
headache syndromes, the next step is to divide the primary
headaches  based on average monthly  frequency o f t he
attacks. Doing so, we divide patients into those of low-to-
moderate frequency (<15 headache days per month), or
those of high frequency (≥15 headache days per month).
Second, based on average duration of a typical untreated
headache attack, we further classify the  headache syn-
drome as short-duration (<4 h a day) or long-duration (4
h) [25].
The chronic daily headaches of shorter duration (Fig. 3)
As discussed previously, headaches that happen on more
than 15 days per month, for less than 4 hours per day, are
usually not referred to as CDHs. They belong to a group
called the trigeminal autonomic cephalalgias (TACs) [26].
The TACs include the episodic and chronic cluster
headache, episodic and c hronic paroxysmal  hemicrania,
short unilateral neuralgiform headache with conjunctival
injection and tearing (SUNCT) syndrome, and hypnic
headache.
The TACs are characterised by unilateral pain in the T T
trigeminal distribution, with ipsilateral autonomic fea-
tures. The most common disorder in this family is cluster
headache (CH). The pain of CH is described variously as
sharp, boring, drilling, knife-like, piercing or stabbing, in
contrast to the pulsating pain of migraine. It usually peaks
in 10–15 min but remains excruciatingly intense for an
average of 1 hour within a duration range of 15–180 min.
During this pain, patients  find  it  difficult to lie still,
exhibiting o ften marked a gitation and restlessness, and
autonomic features are usually obvious. After an attack,
the patient remains exhausted for some time [26, 27].
Like CH, the paroxysmal hemicranias are characterised
by unilateral attacks of trigeminal pain and autonomic fea-
tures. In contrast with CH, the paroxysmal  hemicranias
have three main features: (1) more frequent (more than
five per day); (2) short duration (2–30 min); and (3)
absolute response to therapeutic doses of  indomethacin.
They are rare [28, 29].
The third TAC, SUNCT, is a very rare primary
headache. The diagnostic criteria require at least 20 high-
frequency attacks (3–200 per day) of unilateral orbital,
supraorbital or temporal stabbing or pulsating pain, lasting
5–240 s and accompanied by ipsilateral conjunctival injec-
tion and lacrimation. The attacks are characteristically dra-
matic, with moderately severe pain peaking in intensity
within 3 s and prominent tearing [30].
Hypnic headache is a primary headache disorder of the
elderly, characterised by short-lived attacks (typically 30
min) of nocturnal head pain that awakens the patient at a
constant time each night, in many cases on more nights
Fig. 3 Short duration headachesthan not. It does not occur outside sleep. Hypnic headache
is usually bilateral (though unilaterality does not exclude
the diagnosis) and usually mild to moderate, very different
from the unilateral orbital or periorbital knife-like intense
pain of cluster headache. Autonomic features are absent
[31, 32].
Chronic daily headaches of long duration (Fig. 4)
There are four CDHs of long duration, which are discussed
here. According to the S-L criteria, all subtypes are subdi-
vided into with or without medication overuse. According
tot he Second Edition of the International Classification of
the Headache Disorders (ICHD-2), a CDH with medica-
tion overuse should be classified as medication overuse
headache (MOH) regardless of the phenotype. Therefore,
in the following section we first describe the four subtypes
of the CDH and then separately describe MOH.
Chronic or transformed migraine r r
The terms chronic migraine (CM) and transformed
migraine (TM) are frequently used interchangeably,
although since the publication of ICHD-2 this is no longer
appropriate [33]. Although the two are related, they are
different clinical entities with specific definitions.
Patients with TM/CM typically have a past history of
migraine. It is more frequent in women with a past history
of migraine without aura. Subjects usually report a process
of transformation over months or years, and as headache
increases in frequency, associated symptoms become less
severe and frequent. The process of transformation fre-
quently ends in a pattern of daily or nearly daily headache
that resembles chronic tension-type headache, with some
attacks of full-migraine superimposed [1–3, 34, 35]. In the
clinical setting, migraine transformation most often  is
related to acute medication overuse,  but transformation
may occur without overuse. In the more general popula-
tion, most cases of TM are not related to medication
overuse [36]. Multiple risk factors may be involved in
these cases.
The S-L criteria  identify three potential  links to
migraine  in TM: (A) a prior  history of ICHD defined
migraine; (B) a period of escalating headache frequency;
and (C) concurrent superimposed attacks of migraine that
fulfil the IHS criteria. TM is subdivided into with or with-
out medication overuse. If frequent migraine develops de
novo in a previously headache-free subject, the diagnosis
is new daily persistent headache according to S-L criteria.
The ICHD-2 criteria for CM initially required 15 or more
days of m igraine per month [33], but these criteria were
shown to be too restrictive for clinical practice and research
Fig. 4 CDHs of long duration
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[37–41]. As a consequence, the ICHD-2 criteria for CM
(ICHD-2R) were recently revised in the Appendix of the
classification (Table 3) [42]. CM-R is now defined by CDH
plus 8 or more days of migraine as evidenced by headaches
that meet ICHD-2 criteria  for migraine without aura or
headache with response to acute treatment with a migraine-
specific medication (triptan or ergotamine compound). As
previously stated, if subjects are overusing acute medication
they should be classified as having MOH [42, 44].
A recent study compared the criteria for CM-R and TM
in a headache specialty clinic. Of 158 patients with TM, just
5.6% met the old ICHD-2 criteria for CM. According to the
ICHD-2R, a total of 92.4% met the revised criteria for CM
(p ( <0.001  vs. ICHD-2), which represents a significant
improvement. Subjects with TM and medication overuse
should be classified as MOH (Table 4), and not CM+,
according to the ICHD-2R. Nonetheless, the same study
assessed the proportion of them who had ≥8 days of migraine
per month. Of the 399 individuals with TM+, just 10.2%
could be classified as CM+ in the ICHD-2. However, most
(349, 86.9%) had ≥8 days of migraine per month and could
be classified as MOH and probable CM in the ICHD-2R
(p ( ( <0.001 vs. ICHD-2). The study concluded that the new cri-
teria  for  CM address most of t he criticism towards the
ICHD-2 and should be adopted in clinical practice and
research. In the population where use of specific acute
migraine medications  is  less common, the agreement
between ICHD-2R CM and TM may be less robust [43].
CM/TM in adolescents and adults C C
Differences exist regarding the clinical presentation of TM
in adolescents and adults. Most adults with TM have fewer
than 15 days of full blown migraine per month and more
days of headache resembling tension-type headache than
of migraine. In contrast, TM in adolescents is replete with
migraine attacks. Medication overuse is more common in
adults (84.0%) than in adolescents (58.9%) [45].
Phenotype of CM/TM changes over time
In a recent study of 402 subjects with TM, the proportion of
migraine attacks decreased with age (with a proportional
increase of tension-type headache attacks), from 71% below
the age of 30 years to 22% at age 60 or above. It was high-
er in those with shorter interval from the onset of migraine
to the onset of CDH (less than 5 years, p=0.003), and in
those with a more recent onset of CDH (less than 6 years,
p<0.0001). These findings suggest that CM (15 or more
days of migraine per month) is the first stage of migraine
chronicity in most patients. Subsequently, the frequency of
clearcut migraine attacks  diminishes.  Thus, CM may  be
viewed as the earlier stage of TM, and both are different f f
evolutive stages of a chronic migrainous process [46].
The concept that early in the process of transformation
Table 3 Diagnostic criteria for primary chronic daily headaches according to the International Classification of Headache Disorders (2006)
Revised Criteria and the Silberstein-Lipton Criteria
Silberstein-Lipton From 1996 ICHD-2R
Transformed migraine Chronic migraine
A. Daily or almost daily (>15 days a month) head pain for >1 month Diagnostic criteria:
B. Average headache duration of >4 h per day (if untreated) Headache on ≥15 days/month for >3 months.
C. At least one of the following: Occurring in a patient with at least 5 prior migraine attacks.
1. History of episodic migraine meeting any IHS criteria 1.1–1.6 On ≥8 days per month, for at least three months, headache fills 
2. History of increasing headache frequency with decreasing criteria C1 and C2
severity of migrainous features over at least 3 months
3. Headache at some time meets IHS criteria for migraine 1.
1.1–1.6 other than duration Unilateral
Throbbing
Moderate or severe r r
D. Does not meet criteria for new daily persistent headache (4.7)  Aggravated by physical activity
or hemicrania continua (4.8) Nausea and/or vomiting
Photophobia and phonophobia
2. Tr T T eated or relieved with triptans or ergotamine compounds. r r
D. No medication overuse and not attributable to another causative
disorder.
IHS, International Headache Societymost headache days fill criteria for migraine, and as dis-
ease evolves, the headache attacks become less typical, has
also been supported by an adolescent study, where those
with recent-onset CDH were much more likely to have 15
or more migraine days per month (74.5% vs. 25.8%,
p<0.001) [47].
Because the phenotype of CM/TM changes over time,
CM is frequently misdiagnosed as CTTH.
Chronic tension-type headache
CTTH represents half of the CDH cases found in population
studies, but just a small fraction of those found in specialty
clinics [48]. It is the only CDH that the ICHD-I considered
as a single diagnosis. The criteria remained little changed in
the ICHD-II. Despite the fact that ICHD-I and ICHD-II cri-
teria  distinguish  between episodic and CTTH, the  latter
headache type remains surprisingly poorly studied. This can
be partially explained by the confusion between CTTH and
TM with a low frequency of superimposed migraine attacks.
The prevalence of CTTH is markedly lower than that of
episodic tension-type headache (ETTH), the most prevalent
primary headache disorder. Its 1-year prevalence estimates
range from 1.7% to 2.2% [48, 49]. The female preponder-
ance of CTTH is greater than that of ETTH but lower than
that of migraine. In the USA, the prevalence of CTTH was
reported to be 2.8 in women and 1.4 in men, with an overall
gender prevalence ratio of 2.0. The  prevalence of CTTH
increases with age [50].
The distinguishing pain features of CTTH are bilateral
location, nonpulsating quality, mild to moderate intensity
and lack of aggravation by routine physical activity. The pain
is unaccompanied by nausea, although just one of photopho-
bia or phonophobia does not exclude the diagnosis. In other
words, CTTH is defined by what it is not (i.e., migraine)
[51].
The S-L criteria reserve the diagnosis of CTTH if the
CDH develops abruptly (de novo). It is inferred that this is
also true in the ICHD-II criteria, although this feature of evo-
lution is described in the notes but is not part of the formal
criteria.
New daily persistent headache
CDH may begin without a history of evolution from episod-
ic headache. NDPH is characterised by the relatively abrupt
onset of an unremitting primary CDH; i.e., a patient without
a previous headache syndrome develops a CDH that does not
remit. The patient’s remembering the circumstances, place
and date that the headache began is a pathognomonic feature.
It is the new onset of this primary daily headache that is the
most important feature [52]. The clinical features of the pain
are not considered in making the diagnosis, which simply
requires absence of history of evolution from migraine or
ETTH [1]. The ICHD-II addresses NDPH as a single diagno-
sis in those with a new-onset CDH that resembles CTTH. A
new-onset CDH with migrainous features cannot be classi-
fied as NDPH according to the ICHD-II criteria whereas the
S-L classification allows this  diagnosis  in patients with
headache features of migraine or ETTH if the disorder aris-
es abruptly.
Table 4 T T Classification of the medication overuse subtypes according to the ICHD-2
ICHD-2 code Diagnosis Amount of medication
8.1 Ergotamine overuse headache Ergotamine intake on ≥10 days per month on a regular basis for >3 months
8.2 Triptan overuse headache Triptan intake (any formulation) on  T T ≥10 days per month on a regular basis
for >3 months
8.3 Analgesic overuse headache Intake of simple analgesics on ≥15 days per month on a regular basis
for >3 months
8.4 Opioid overuse headache Opioid intake on ≥10 days per month on a regular basis for >3 months
8.5 Combination analgesic overuse headache Intake of combination analgesic medications on ≥10 days per month 
on a regular basis for >3 months
8.6 MOH attributed to combination  Intake of any combination of ergotamine, triptans, analgesics, and/or
of acute medications opioids on ≥10 days per month on a regular basis for >3 months 
without overuse of any single class
8.7 Headache attributed to other Regular overuse for >3 months of a medication other than those
medication overuse described above
8.8 Probable MOH Overused medication has not yet been withdrawn or medication overuse
has ceased within the last 2 months but headache has not so far resolved
or has reverted to its previous pattern
270271
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